Strategies to improve plasma half life time of peptide and protein drugs

Amino Acids
M Werle, A Bernkop-Schnürch

Abstract

Due to the obvious advantages of long-acting peptide and protein drugs, strategies to prolong plasma half life time of such compounds are highly on demand. Short plasma half life times are commonly due to fast renal clearance as well as to enzymatic degradation occurring during systemic circulation. Modifications of the peptide/protein can lead to prolonged plasma half life times. By shortening the overall amino acid amount of somatostatin and replacing L: -analogue amino acids with D: -amino acids, plasma half life time of the derivate octreotide was 1.5 hours in comparison to only few minutes of somatostatin. A PEG(2,40 K) conjugate of INF-alpha-2b exhibited a 330-fold prolonged plasma half life time compared to the native protein. It was the aim of this review to provide an overview of possible strategies to prolong plasma half life time such as modification of N- and C-terminus or PEGylation as well as methods to evaluate the effectiveness of drug modifications. Furthermore, fundamental data about most important proteolytic enzymes of human blood, liver and kidney as well as their cleavage specificity and inhibitors for them are provided in order to predict enzymatic cleavage of peptide and protein drugs during systemic cir...Continue Reading

References

May 1, 1977·The Biochemical Journal·D V MarinkovicC J Robinson
Oct 14, 1977·Science·A M ReisenauerC H Halsted
Feb 10, 1978·Biochimica Et Biophysica Acta·M SugiuraS Sawaki
May 1, 1979·Journal of Reproduction and Fertility·S Lampelo, T Vanha-Perttula
Jan 1, 1976·Methods in Enzymology·G H LittleF J Behal
Feb 15, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·D Mantle
Feb 28, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·D MantleA Gibson
Jan 1, 1991·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·C M SuT F Mowles
Aug 1, 1990·Biochemical Society Transactions·T LeesD Mantle
Jan 31, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·T OhhashiH Kodama
Jan 1, 1987·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·J F GregoryJ J Cerda
Apr 24, 1987·Journal of Chromatography·T SakaiT Nagatsu
Jun 15, 1985·The Biochemical Journal·J F LenneyR P George
Oct 1, 1973·Journal of Pharmacokinetics and Biopharmaceutics·R L Dedrick
Jan 1, 1980·Biochimica Et Biophysica Acta·J B McClellan, C W Garner
Feb 1, 1981·Biochemical Society Transactions·E E SterchiM J Lentze
Jun 1, 1984·Gastroenterologia Japonica·M SugimotoK Kawai
Nov 1, 1980·The Biochemical Journal·W N Schwartz, A J Barrett
Nov 1, 1981·Journal of Biochemistry·Y TakadaT Kokubu
Jan 1, 1981·Methods in Enzymology·T A StewartE G Erdös
Jun 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·Y SawadaT Iga
Aug 18, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·J F LenneyG S Rinzler
Apr 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·H Boxenbaum
Jan 1, 1981·Methods in Enzymology·C E Odya, E G Erdös
Jan 1, 1994·Drugs·S Kazda
May 1, 1995·International Journal of Peptide and Protein Research·J PinskiB Kutscher
Jan 1, 1995·Bioconjugate Chemistry·C MonfardiniF M Veronese
Jan 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y IkedaA Meister
Sep 1, 1994·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R CivitelliR Y Tsien

❮ Previous
Next ❯

Citations

Apr 30, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Meltem OcakClemens Decristoforo
Jun 23, 2011·Pharmaceutical Research·Phanidhara KotamrajXiaoling Li
Jul 7, 2011·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Elisabeth von GuggenbergClemens Decristoforo
May 31, 2013·Clinical Pharmacokinetics·Lei Diao, Bernd Meibohm
Jun 25, 2013·European Journal of Medicinal Chemistry·Giulio VistoliGiancarlo Aldini
May 28, 2011·ACS Chemical Biology·Jennifer A GetzPatrick S Daugherty
Oct 24, 2012·Journal of Medicinal Chemistry·Alessandro AngeliniChristian Heinis
Jan 5, 2012·Nature Communications·Jan Terje AndersenInger Sandlie
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Taia T WangPeter Palese
Oct 12, 2012·The Journal of Antimicrobial Chemotherapy·Ernest A AzzopardiDavid W Thomas
Jul 9, 2010·Current Opinion in Hematology·David Lillicrap
Nov 23, 2006·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Martin GotthardtWim J G Oyen
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·Yong Pyo ShinIn Hee Lee
Dec 8, 2006·Journal of Virology·Fengwei BaiErol Fikrig
Nov 16, 2012·Cancer Research·Luca AlbericiErkki Ruoslahti
Apr 23, 2008·Pediatric Research·Serge Kobsa, W Mark Saltzman
Dec 19, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hong-Bo PangErkki Ruoslahti
Oct 27, 2012·Advanced Drug Delivery Reviews·Kwang-Chul KwonHenry Daniell
May 2, 2014·Journal of Molecular Endocrinology·Tamar Eigler, Anat Ben-Shlomo
Dec 11, 2013·Bioanalysis·Stacey L RichardsMark J Raftery
Feb 23, 2011·Natural Product Reports·Charles R RobertsonGrzegorz Bulaj
Jul 31, 2013·Drug Delivery and Translational Research·Lipa ShahMansoor Amiji
Oct 9, 2013·Molecular Pharmaceutics·Lucas W E StarmansHolger Grüll

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.